Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Edinburgh Partners Continues To Trim Top Picks Amid 2015 Struggles

Page 1 of 2

Sandy Nairn’s Edinburgh Partners has filed its 13F with the SEC for the reporting period of June 30, 2015. At Insider Monkey, we keep an eye out for major changes in the public equity portfolios of hedge fund managers. Mr. Nairn has an equity portfolio valued at $907.33 million as of the end of the second quarter, with his primary investment sector being information technology and consumer discretionary. During the second quarter, Edinburgh Partners trimmed many of its top positions (nine out of its top ten positions as of June 30 were reduced during the previous quarter, and those positions accounted for 95% of the fund’s portfolio), including Carnival Corp (NYSE:CCL) and Microsoft Corporation (NASDAQ:MSFT), which happened to be two of his better performing stocks last quarter. The fund manager initiated two new stock positions during the second quarter in PerkinElmer, Inc. (NYSE:PKI) and Allergan PLC (NYSE:AGN). The fund manager has struggled in 2015 according to our returns metric, particularly in the second quarter. His 37 long positions as of March 31 in stocks with a market cap of $1 billion or more, delivered a weighted average returns loss of 2.6%. For the first half of the year, that figure stands at a loss of 3.3%. It should be noted that these calculations exclude bonds and options, and positions in micro- or nano-cap companies, so the actual returns may be very different from our approximations.

Sandy Nairn

We don’t just track the latest moves of funds. We are, in fact, more interested in their 13F filings, which we use to determine the top 15 small-cap stocks held by the funds we track. We gather and share this information based on 16 years of research, with backtests for the period between 1999 and 2012 and forward testing for the last 2.5 years. The results of our analysis show that these 15 most popular small-cap picks have a great potential to outperform the market, beating the S&P 500 Total Return Index by nearly one percentage point per month in backtests. Moreover, since the beginning of forward testing in August 2012, the strategy worked brilliantly, outperforming the market every year and returning 135%, which is more than 80 percentage points higher than the returns of the S&P 500 ETF (SPY) (see more details).

Carnival Corp (NYSE:CCL) is the largest equity investment of Edinburgh Partners, which owns 2.23 million shares valued at $111.39 million, the position trimmed by 2% during the second quarter. The shares of the cruise vacation company have actually bucked the Edinburgh trend, having grown by 15.19% year-to-date and offered returns of 3.24% in the second quarter. Carnival Corp had an excellent second quarter, with reported GAAP net income of $222 million against its net income of $98 million from a year ago. Its quarterly revenue was in line with the prior year period at $3.6 billion. The shares of Carnival Corp (NYSE:CCL) have received an average analyst rating of ‘Buy’ from 22 analysts. The carnival company received approval for setting limited sales to Cuba from the U.S. government starting in May 2016. Carnival Corp plans to use its social-impact brand, Fathom, for the visits, and these tours differ from traditional tour offerings in terms of their emphasis over cultural exchange and immersion. Kerr Neilson’s Platinum Asset Management was the largest shareholder of Carnival Corp (NYSE:CCL) among the funds we track as of March 31, with a holding valued at $453.62 million from ownership of 9.48 million shares.

Sandy Nairn
Sandy Nairn
Edinburgh Partners
Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!